BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 38534324)

  • 1. Inhibition of neuraminidase-1 sialidase activity by interfering peptides impairs insulin receptor activity in vitro and glucose homeostasis in vivo.
    Toussaint K; Appert-Collin A; Vanalderwiert L; Bour C; Terryn C; Spenlé C; Van Der Heyden M; Roumieux M; Maurice P; Romier-Crouzet B; Sartelet H; Duca L; Blaise S; Bennasroune A
    J Biol Chem; 2024 Apr; 300(6):107316. PubMed ID: 38663826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The landscape of cancer rewired GPCR signaling axes.
    Arora C; Matic M; DiChiaro P; Rosa NO; Carli F; Clubb L; Fard LAN; Kargas G; Diaferia G; Vukotic R; Licata L; Wu G; Natoli G; Gutkind JS; Raimondi F
    bioRxiv; 2023 Oct; ():. PubMed ID: 37398064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytocannabinoids CBD, CBG, and their Derivatives CBD-HQ and CBG-A Induced In Vitro Cytotoxicity in 2D and 3D Colon Cancer Cell Models.
    Bęben D; Siwiela O; Szyjka A; Graczyk M; Rzepka D; Barg E; Moreira H
    Curr Issues Mol Biol; 2024 Apr; 46(4):3626-3639. PubMed ID: 38666957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biased G protein-coupled receptor agonism mediates Neu1 sialidase and matrix metalloproteinase-9 crosstalk to induce transactivation of insulin receptor signaling.
    Haxho F; Haq S; Szewczuk MR
    Cell Signal; 2018 Mar; 43():71-84. PubMed ID: 29277445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neu1 sialidase and matrix metalloproteinase-9 cross-talk regulates nucleic acid-induced endosomal TOLL-like receptor-7 and -9 activation, cellular signaling and pro-inflammatory responses.
    Abdulkhalek S; Szewczuk MR
    Cell Signal; 2013 Nov; 25(11):2093-105. PubMed ID: 23827939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-protein coupled receptor agonists mediate Neu1 sialidase and matrix metalloproteinase-9 cross-talk to induce transactivation of TOLL-like receptors and cellular signaling.
    Abdulkhalek S; Guo M; Amith SR; Jayanth P; Szewczuk MR
    Cell Signal; 2012 Nov; 24(11):2035-42. PubMed ID: 22759791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Molecular Mechanism of Aspirin and Celecoxib Targeting Mammalian Neuraminidase-1 Impedes Epidermal Growth Factor Receptor Signaling Axis and Induces Apoptosis in Pancreatic Cancer Cells.
    Qorri B; Harless W; Szewczuk MR
    Drug Des Devel Ther; 2020; 14():4149-4167. PubMed ID: 33116404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
    Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
    Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Selectivity of Cannabinoid Type 1 G Protein-Coupled Receptor Agonists in Transactivating Glycosylated Receptors on Cancer Cells to Induce Epithelial-Mesenchymal Transition Metastatic Phenotype.
    Bunsick DA; Matsukubo J; Aldbai R; Baghaie L; Szewczuk MR
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological selection of cannabinoid receptor effectors: Signalling, allosteric modulation and bias.
    Manning JJ; Green HM; Glass M; Finlay DB
    Neuropharmacology; 2021 Aug; 193():108611. PubMed ID: 34000272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists.
    Wouters E; Walraed J; Banister SD; Stove CP
    Biochem Pharmacol; 2019 Nov; 169():113623. PubMed ID: 31472128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis for ligand modulation of the cannabinoid CB
    Ramesh K; Rosenbaum DM
    Br J Pharmacol; 2022 Jul; 179(14):3487-3495. PubMed ID: 34265078
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.